Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Dermatological Tumors”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT04751396
What this trial is testing

Testing of an Educational Tool for Patients With Melanoma and Pre-Existing Autoimmune Disease Who Are Candidates for Immune Checkpoint Inhibitors

Who this might be right for
Ankylosing SpondylitisAutoimmune DiseaseCrohn Disease+10 more
M.D. Anderson Cancer Center 125
Testing effectiveness (Phase 2)Looking for participantsNCT04787042
What this trial is testing

Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067

Who this might be right for
CancerSolid TumorMelanoma+6 more
Simcha IL-18, Inc. 316
Very early researchActive Not RecruitingNCT05358938
What this trial is testing

Exercise to Boost Response to Checkpoint Blockade Immunotherapy

Who this might be right for
Cutaneous MelanomaCutaneous Squamous Cell CarcinomaMerkel Cell Carcinoma
H. Lee Moffitt Cancer Center and Research Institute 22
Not applicableStudy completedNCT02623101
What this trial is testing

Reflectance Confocal Microscopy in Basal Cell Carcinoma

Who this might be right for
Carcinoma, Basal Cell
Radboud University Medical Center 288
Early research (Phase 1)Study completedNCT00001439
What this trial is testing

A Phase I Study of gp100 Human Melanoma Peptide Vaccine With Incomplete Freund's Adjuvant

Who this might be right for
Melanoma
National Cancer Institute (NCI) 255
Testing effectiveness (Phase 2)Study completedNCT00308607
What this trial is testing

Bevacizumab, Dacarbazine and Interferon-Alfa to Treat Metastatic Melanoma

Who this might be right for
Metastatic Melanoma
University of Turku 27
Not applicableUnknownNCT01536444
What this trial is testing

Use of the Epidermal Micrografts for Wound Healing After Mohs or Excisional Surgery for Skin Cancer

Who this might be right for
Neoplasm of Skin
Momelan Technologies 12
Not applicableUnknownNCT03775031
What this trial is testing

Chemical Peels and Fractional Laser on IGF-1 Levels in Skin

Who this might be right for
Skin Cancer
Massachusetts General Hospital 20
Not applicableUnknownNCT05421377
What this trial is testing

Development of a Clinical Screening, Diagnostic and Evaluation Tool for Patients With Lower Limb Lymphedema: Aim 2

Who this might be right for
Lower Limb Lymphedema
KU Leuven 120
Not applicableStudy completedNCT02975700
What this trial is testing

PLX3397 in Patients With Unresectable or Metastatic KIT-mutated Melanoma

Who this might be right for
Melanoma
Daiichi Sankyo Co., Ltd. 6
Large-scale testing (Phase 3)Looking for participantsNCT06624644
What this trial is testing

A Trial of LNS8801 With or Without Pembrolizumab in Patients With Refractory Melanoma

Who this might be right for
Melanoma (Skin Cancer)Melanoma Stage IIIB-IVCutaneous Melanoma+1 more
Linnaeus Therapeutics, Inc. 135
Not applicableUnknownNCT02361229
What this trial is testing

Skin Cancer in Swiss Transplant Cohort Study

Who this might be right for
Skin Cancer
University of Zurich 4,000
Testing effectiveness (Phase 2)Temporarily pausedNCT01988831
What this trial is testing

Efficacy of Propranolol Treatment to Prevent Melanoma Progression

Who this might be right for
Stages III Skin MelanomaStages II Skin MelanomaStage IB Skin Melanoma
University Hospital, Geneva 450
Very early researchStudy completedNCT01666353
What this trial is testing

PET Quantitative Assessments of Solid Tumor Response to Immune Checkpoint Blockade Therapy

Who this might be right for
MelanomaRenal Cell Carcinoma (RCC)Non-small Cell Lung Cancer (NSCLC)
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 20
Testing effectiveness (Phase 2)Study completedNCT03620019
What this trial is testing

Denosumab + PD-1 in Subjects With Stage III/ IV Melanoma

Who this might be right for
Melanoma Stage IiiMelanoma Stage IvMelanoma+2 more
UNC Lineberger Comprehensive Cancer Center 25
Testing effectiveness (Phase 2)Study completedNCT00445965
What this trial is testing

Iodine I 131 Monoclonal Antibody 3F8 in Treating Patients With Central Nervous System Cancer or Leptomeningeal Cancer

Who this might be right for
Brain and Central Nervous System TumorsIntraocular MelanomaLung Cancer+7 more
Memorial Sloan Kettering Cancer Center 78
Not applicableEnded earlyNCT02650492
What this trial is testing

Immunostimulating Interstitial Laser Thermotherapy in Malignant Melanoma

Who this might be right for
MelanomaMalignant Melanoma
Clinical Laserthermia Systems AB 2
Testing effectiveness (Phase 2)Study completedNCT01290536
What this trial is testing

Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases

Who this might be right for
Colorectal NeoplasmsNeuroendocrine TumorsCholangiocarcinoma+2 more
Nicholas Fidelman, MD 42
Not applicableActive Not RecruitingNCT07022457
What this trial is testing

UK ENcorafenib and BInimetinib Real-world Study in Melanoma

Who this might be right for
Metastatic Melanoma, BRAF V600 Mutation Positive
Pierre Fabre Ltd 50
Not applicableStudy completedNCT04336371
What this trial is testing

Exploratory Prospective of Experienced by Patients in the Surgery of Skin Cancers of the Face in Interventional Dermatology Department

Who this might be right for
Skin Cancer FaceSurgical Incision
University Hospital, Bordeaux 98
Next Page